Prometheus Biosciences Inc Shares Close the Day 17.1% Higher - Daily Wrap
The company saw its shares close the day 17.1% higher than yesterday, with trading volume lower than its 30 day average.
Jan 15, 2022 by Kwhen Finance Editors
Prometheus Biosciences Inc (RXDX) shares closed today 17.1% higher than it did at the end of yesterday. The stock is currently down 10.7% year-to-date, up 39.5% over the past 12 months, and up 39.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%.
Trading Activity
- Shares traded as high as $36.87 and as low as $29.50 this week.
- Shares closed 12.8% below its 52-week high and 119.1% above its 52-week low.
- Trading volume this week was 43.4% higher than the 10-day average and 1.3% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
- The stock closed at 8.6% higher than its 5-day moving average, 0.6% lower than its 20-day moving average, and 15.4% higher than its 90-day moving average.
Market Comparative Performance
- The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Prometheus Biosciences Inc | 17.1 | -10.7 | 39.5 | -26.9 | 83.7 |
| Dow Jones Industrial Average | -0.6 | -1.2 | 17.8 | -3.1 | 22.0 |
| S&P 500 Index | 0.0 | -2.2 | 24.4 | -3.9 | 26.9 |
| Technology Industry | -2.5 | 16.9 | -62.2 | -64.1 | 26.0 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 115.7%
- The company's stock price performance over the past 12 months beats the peer average by -229.3%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Prometheus Biosciences Inc | RXDX | 0 | -10.7 | 39.5 | -26.9 | 83.7 |
| Peer Avg | N/A | 52.0 | -5.0 | -30.6 | -49.7 | 5.2 |
| Agenus Inc | AGEN | 208.0 | -5.3 | -10.8 | -57.3 | 16.0 |
| Akebia Therapeutics Inc. | AKBA | 0 | -2.7 | -30.6 | -58.8 | 3.9 |
| Epizyme Inc | EPZM | 0 | -12.0 | -80.9 | -82.8 | 0.9 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: